Drugmaker Sun Pharmaceuticals said on Thursday its unit had received US regulatory approval to market a generic version of GlaxoSmithKline8217;s Wellbutrin SR extended release tablets.
These tablets are used in the treatment of depressive disorders,it said in a statement.